We are excited to announce the next stage in our relationship with the Rudi Schulte Research Institute (RSRI) as we partner with them to find significant advances in the treatment of hydrocephalus. RSRI has long been the sponsor of our research keynote speaker at our bi-annual education conference.
This year, they expanded their partnership with us to co-sponsor our hydrocephalus research conference – “Opportunities in Hydrocephalus Research: Pathways to Better Outcomes” in Seattle in July 2012. That sponsorship was intended to help RSRI develop a picture of promising hydrocephalus research for the Institute to tackle. Having completed the consensus conference, we have now partnered with RSRI to launch a major new Request for Applications (RFA) targeted at gaining a better understanding of the dynamics of Cerebrospinal Fluid (CSF). This RFA expands on the work that we funded starting in 2011 to not only consider therapeutic targets but to also consider discovery of new pathways or diagnostic biomarkers. The current RFA requires that researchers submit a Letter of Intent by January 4, 2013, with applications being finalized by March 1, 2013.
RSRI plans to commit a significant effort to the most promising research in this area. At the conclusion of our review process, they expect to select one or two researchers and invest at least $600,000 in advancing this research over three years. HA will consider further augmenting the investment in these applications to bring the total investment up to $1M over the next three years. These research areas were described in our five- year Research Initiative plan and represent significant potential to alter the course of diagnosis and treatment for those who suffer from hydrocephalus.
Rudi Schulte was one of the two founders of PS Medical which developed the Delta and Strata valves. The company was later sold to Medtronic, which has continued to advance those shunt technologies. Rudi Schulte founded the Rudi Schulte Research Institute (RSRI) in 1974 to continue research into hydrocephalus. The Hydrocephalus Association is pleased to have expanded our partnership to help RSRI target research that is meaningful to our members.